Abstract:HBV cccDNA is the persistent form of viral genome, which exists in host cell nucleus as an episomal minichromosome decorated with histone and non-histone proteins. cccDNA is the authentic viral transcript template and resistant to current antivirals. Growing evidence shows that the transcriptional activity of cccDNA minichromosome undergoes epigenetic regulations, suggesting a new perspective for anti-cccDNA drug development through targeting histone modifications. In this study, we screened an epigenetic compound library in the cccDNA reporter cell line HepBHAe82, which produces the HA-tagged HBeAg in a cccDNA-dependent manner. Among the obtained hits, a bromodomain-containing protein 4 (BRD4) inhibitor MS436 exhibited marked inhibition of cccDNA transcription in both HBV stable cell line HepAD38 and HepG2-NTCP or primary human hepatocyte infection system under noncytotoxic concentrations. Chromatin immunoprecipitation (ChIP) assay demonstrated that MS436 dramatically reduced the enrichment of H3K27ac, an activating histone modification pattern, on cccDNA minichromosome. RNAseq differential analysis showed that MS436 does not drastically change host transcriptome or induce any known anti-HBV factors/pathways, indicating a direct antiviral effect of MS436 on cccDNA minichromosome. Interestingly, the MS436-mediated inhibition of cccDNA transcription is accompanied by cccDNA destabilization in HBV infection and a recombinant cccDNA system, indicating that BRD4 activity may also play a role in cccDNA maintenance. Furthermore, depletion of BRD4 by siRNA knockdown or PROTAC degrader resulted in cccDNA inhibition in HBV-infected HepG2-NTCP cells, further validating BRD4 as an antiviral target. Taken together, our study has demonstrated the practicality of HepBHAe82-based anti-HBV drug screening system and provided a proof-of-concept for targeting HBV cccDNA with epigenetic compounds.

Identification of Estradiol Benzoate as an Inhibitor of HBx Using Inducible Stably Transfected HepG2 Cells Expressing HiBiT Tagged HBx

Establishment of an in Vitro Reporter System for Screening HBx-targeting Molecules

HBx-Derived Constrained Peptides Inhibit the Secretion of Hepatitis B Virus Antigens

Proteomic Profiling Identifies Aberrant Epigenetic Modifications Induced by Hepatitis B Virus X Protein

Creation of a Six-fingered Artificial Transcription Factor That Represses the Hepatitis B Virus HBx Gene Integrated into a Human Hepatocellular Carcinoma Cell Line

Evaluation of Hepatitis B Viral Replication and Proteomic Analysis of HepG2.2.15 Cell Line after Knockdown of HBx

[Mechanism and Clinical Significance of HBx-mediated Inhibition of CYP2E1 Expression in the Human HepG2 Hepatoma Cell Line].

Inhibition of Hepatitis B Virus Gene Expression by Single and Dual Small Interfering RNA Treatment

A Polypeptide D-TTK001 Targeting HBx Controls Cccdna Against HBV

Identification of Differentially Expressed Genes in HBxAg Transfected HepG2 Cells by Suppression Subtractive Hybridization

Establishment of Cell Lines Using a Doxycycline-Inducible Gene Expression System to Regulate Expression of Hepatitis B Virus X Protein

Gene Expression Profiles of Human Liver Cells Mediated by Hepatitis B Virus X Protein

Downregulation of HBx mRNA in HepG2.2.15 cells by small interfering RNA.

Inhibitory Effects of Small Hairpin RNA on Hepatitis B Virus X Protein in Vitro

Screening of an epigenetic compound library identifies BRD4 as a potential antiviral target for hepatitis B virus covalently closed circular DNA transcription

Mechanism of the inhibitory effect of HBx on IGFBP3 transcription

Human Hepatitis B Virus X Protein Promotes Cell Proliferation and Inhibits Cell Apoptosis Through Interacting with a Serine Protease Hepsin.

HBX Expression Inhibtion by RNA Interference Suppress on Invasive Growth of Human Hepatocellular Carcinoma Cells HepG2.215 in vitro

Epigenetic modification induced by hepatitis B virus X protein via interaction with de novo DNA methyltransferase DNMT3A

Using Proteomics to Identify the HBx Interactome in Hepatitis B Virus: How Can This Inform the Clinic?

Progressive Changes in Hepatoma Cells Stably Transfected with Hepatitis B Virus X Gene